Takeo Fujii

机构：National Institutes of Health, National Cancer Institute, National Cancer Institute · ORCID：0000-0003-3747-2688

发表论文 141 篇 · 总被引 2437 次 · h-index 24

代表论文

• Neutrophils drive vascular occlusion, tumour necrosis and metastasis (2025 · Nature · 被引 64)
• Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into “ARness” (2024 · Cell Reports Medicine · 被引 19)
• A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models (2025 · Clinical & Experimental Metastasis · 被引 7)
• Racial and survival disparities in inflammatory breast cancer (IBC) and non-IBC: a population-based study focused on Native Hawaiians and other Pacific Islanders (2024 · Frontiers in Oncology · 被引 7)
• Healthcare provider perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions for breast cancer survivors (2025 · Journal of Cancer Survivorship · 被引 6)
• Revisiting surrogacy of pathological complete response for long-term survival in triple-negative breast cancer (2025 · JNCI Cancer Spectrum · 被引 5)